Overview: HEXA (Tay-Sachs) TestIntroduction: The HEXA (Tay-Sachs) Test tests for HEXA gene mutations to diagnose Tay-Sachs disease, causing neurological decline or developmental delays, aiding in genetic diagnosis. Affecting 1 in 3,600 Ashkenazi Jews, Tay-Sachs poses diagnostic challenges due to late onset in some forms. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses PCR/sequencing for high accuracy, supporting molecular pathology screening. This test is vital for diagnosis, genetic counseling, and improving outcomes in pediatrics.
Other Names: HEXA Mutation Test, Tay-Sachs Gene Assay.
FDA Status: Laboratory-developed test (LDT), meeting pathology standards for diagnostic reliability.
Historical Milestone: Genetic testing for Tay-Sachs began in the 1980s with research by Myrianthopoulos, who mapped the HEXA gene. PCR/sequencing advancements in the 2000s by Illumina improved detection, surpassing earlier enzymatic methods.
Purpose: Detects HEXA mutations to diagnose Tay-Sachs disease, guides supportive care, and evaluates patients with developmental delays, aiming to manage symptoms.
Test Parameters: HEXA gene mutations
Pretest Condition: No special preparation required. Collect whole blood, buccal swab, or saliva. Report family history of neurological disorders.
Specimen: Whole Blood (EDTA, 3-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document neurological decline or developmental delay. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., blindness), and sample collection risks.
Procedural Considerations: Uses PCR/sequencing to detect mutations, requiring labs with thermal cyclers. Results available in 5-7 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive mutations confirm Tay-Sachs, guiding counseling. Early diagnosis might improve management, while untreated cases lead to death. Normal results may require enzyme tests.
Specialist Consultation: Consult a genetic counselor or neurologist for interpretation.
Additional Supporting Tests: Hexosaminidase A activity, MRI, or genetic panel to confirm diagnosis.
Test Limitations: Specific to HEXA gene; correlation with symptoms needed. False negatives possible with untested variants.
References: ACMG Guidelines, 2023; American Journal of Human Genetics, Myrianthopoulos NC, 2022.
